← All indications
Tay-Sachs Disease
An autosomal recessive neurodegenerative disorder characterized by the onset in infancy of an exaggerated startle response, followed by paralysis, dementia, and blindness. It is caused by mutation in the alpha subunit of the HEXOSAMINIDASE A resulting in lipid-laden ganglion cells. It is also known as the B variant (with increased HEXOSAMINIDASE B but absence of hexosaminidase A) and is strongly associated with Ashkenazic Jewish ancestry.
Drugs by status
Phase 4 trials (1)
Phase 2 trials (11)
Phase 1 trials (2)
Organizations
Organization Involved with Phase 4 Indications (6)
Organization Involved with Phase 3 Indications (7)
Organization Involved with Phase 2 Indications (4)
Organization Involved with Phase 1 Indications (7)